XML 91 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
Business Segment Information (Tables)
 3 Months Ended
Dec. 31, 2017
Segment Reporting [Abstract]  
Segment revenue
The following illustrates reportable segment revenue information for the periods indicated:
 
 
Three months ended
December 31,
(in thousands)
 
2017
 
2016
Pharmaceutical Distribution Services
 
$
38,937,698

 
$
36,798,289

Other
 
1,544,951

 
1,384,490

Intersegment eliminations
 
(16,317
)
 
(13,514
)
Revenue
 
$
40,466,332

 
$
38,169,265
Segment operating income
The following illustrates reportable segment operating income information for the periods indicated:
 
 
Three months ended
December 31,
(in thousands)
 
2017
 
2016
Pharmaceutical Distribution Services
 
$
388,182

 
$
379,060

Other
 
100,275

 
107,148

Intersegment eliminations
 
(407
)
 
(13
)
Total segment operating income
 
$
488,050

 
$
486,195
Reconciliation of total segment operating income to income (loss) from operations before income taxes
The following reconciles total segment operating income to income before income taxes for the periods indicated:
 
 
Three months ended
December 31,
(in thousands)
 
2017
 
2016
Total segment operating income
 
$
488,050

 
$
486,195

Gain from antitrust litigation settlements
 
—

 
1,395

LIFO expense
 
—

 
(28,308
)
Acquisition-related intangibles amortization
 
(39,056
)
 
(38,229
)
Employee severance, litigation, and other
 
(30,021
)
 
(21,066
)
Operating income
 
418,973

 
399,987

Other loss (income)
 
324

 
(123
)
Interest expense, net
 
35,864

 
36,972

Loss on early retirement of debt
 
23,766

 
—

Income before income taxes
 
$
359,019

 
$
363,138